Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | CD69 | Q07108 | 1/20 | 0.34 |
| ▸ | TLR4 | O00206 | 3/20 | 0.31 |
| ▸ | CD14 | P08571 | 3/20 | 0.31 |
| ▸ | LY96 | Q9Y6Y9 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17030890 | 0.81 | ELANE (0.33) | ELANECD69 | |
| SCHEMBL17030889 | 0.71 | PTPRC (0.42) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL17030892 | 0.70 | ELANE (0.34) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL6690916 | 0.70 | ELANE (0.45) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL12549814 | 0.70 | CD69 (0.46) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL17030886 | 0.69 | PTPRC (0.42) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL2471228 | 0.67 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL13620669 | 0.67 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL29517201 | 0.67 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 | |
| SCHEMBL30547266 | 0.67 | GABRA1 (0.50) | ELANECD69TLR4CD14LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120316347-A1 | METAL COLLOIDS WITH ACCESSIBLE METAL SURFACES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316347-A1 | METAL COLLOIDS WITH ACCESSIBLE METAL SURFACES | CALR, CALD1, CALU | ELANE 130/4885CD69 1001/4885TLR4 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.